[MNPR] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
27-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -27.82%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,516 -9,103 -6,305 -4,225 -3,300 -16,555 -1,186 43.84%
Tax -21 -24 -82 -99 -72 -2,102 1 -
NP -10,494 -9,079 -6,223 -4,126 -3,228 -16,555 -1,186 43.79%
Tax Rate - - - - - - - -
Total Cost 10,494 9,079 6,223 4,126 3,228 16,555 1,186 43.79%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 40.02%
EPS Diluted -0.83 -0.73 -0.57 -0.39 -0.31 -1.59 -0.11 40.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.